Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib Maintenance in High Grade Bone Sarcomas (REGOMAIN)
NCT04698785Phase 2Recruiting
- Sponsor
- Centre Léon Bérard
- Start
- Jul 2021
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regorafenib in bone sarcoma, osteosarcoma (OS), sponsored by Centre Léon Bérard. Started Jul 2021; status: recruiting.
02
Drugs
regorafenib
03
Conditions
bone sarcomaosteosarcoma (OS)
Beyond the preview
Go deeper on NCT04698785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04698785.